Immunohistochemical evaluation of hematologic malignancies.
This article summarizes the most recent developments and current practice of immunohistochemistry in the diagnosis of hematologic malignancy. Increased availability of monoclonal antibodies applicable in formaldehyde-fixed and paraffin-embedded tissue is discussed as are immunohistochemical definitions for many small cell lymphoma entities. Evaluation is made of the biologic potential of lymphomas and leukemias by the use of antibodies to proliferation antigens, such as Ki-67 and products of tumor suppressor genes (p53).
Department of Pathology, Jefferson Medical College, Philadelphia, Pennsylvania.
M
M
Miettinen
R
R
Schwarting
B H
BH
Hyun
D001402:B-Lymphocytes / Q000276:immunology; D006680:HLA Antigens / Q000032:analysis; D006801:Humans; D007150:Immunohistochemistry; D016130:Immunophenotyping; D007938:Leukemia / Q000145:classification / Q000175:diagnosis* / Q000276:immunology; D008223:Lymphoma / Q000145:classification / Q000175:diagnosis* / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology
D006680:HLA Antigens